Unknown

Dataset Information

Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda.


ABSTRACT:

Introduction

COSTOP was a randomised controlled trial designed to assess the risks and benefits to HIV-infected participants stabilised on anti-retroviral treatment of stopping cotrimoxazole (CTX). In order to assess the extent to which patients may have had access to and used CTX other than that supplied as study drug it was decided to conduct an exit interview.

Methods

A structured interview was administered by interviewers who were not associated with the COSTOP trial team in order to make it easier for participants to respond truthfully to sensitive questions about adherence to the study protocol.

Results

A total of 1993 participants were interviewed. Only 29 (1.7%) said they had taken their left over CTX; 101 (6.1%) had kept supplies at home. When asked about obt

SUBMITTER: Nunn A 

PROVIDER: S-EPMC4918030 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature